Comparison 19. Proportion of subjects deceased.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Proportion of subjects deceased ( 3 months)	2	940	Odds Ratio (M‐H, Fixed, 95% CI)	0.43 [0.10, 1.95]
1.1 galantamine (24‐32mg/d bid) vs placebo	1	386	Odds Ratio (M‐H, Fixed, 95% CI)	0.09 [0.00, 1.98]
1.2 galantamine (32mg/d tds) vs placebo	1	554	Odds Ratio (M‐H, Fixed, 95% CI)	1.01 [0.14, 7.25]
2 Proportion of subjects deceased ( 6 months)	4	4286	Odds Ratio (M‐H, Fixed, 95% CI)	0.95 [0.50, 1.78]
2.1 galantamine (16‐24mg/d bid ) vs placebo	1	651	Odds Ratio (M‐H, Fixed, 95% CI)	0.99 [0.06, 15.91]
2.2 galantamine (16‐24mg/d Prolonged Release ) vs placebo	1	644	Odds Ratio (M‐H, Fixed, 95% CI)	3.06 [0.32, 29.54]
2.3 galantamine (24mg/d bid) vs placebo	3	1576	Odds Ratio (M‐H, Fixed, 95% CI)	0.83 [0.35, 1.98]
2.4 galantamine (32mg/d bid or tds) vs placebo	1	424	Odds Ratio (M‐H, Fixed, 95% CI)	3.04 [0.12, 75.12]
2.5 galantamine (8mg/d bid) vs placebo	1	426	Odds Ratio (M‐H, Fixed, 95% CI)	0.51 [0.06, 4.58]
2.6 galantamine (16mg/d bid) vs placebo	1	565	Odds Ratio (M‐H, Fixed, 95% CI)	0.77 [0.17, 3.46]
3 Proportion of subjects deceased ( 24 months in MCI)	2	1903	Odds Ratio (M‐H, Fixed, 95% CI)	9.33 [1.72, 50.54]
3.1 galantamine (16‐24mg/d bid ) vs. placebo in MCI	2	1903	Odds Ratio (M‐H, Fixed, 95% CI)	9.33 [1.72, 50.54]